Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: Prognostic evaluation of CD5, PD-L1, and Epstein-Barr virus on tumor cells.

Eri IshikawaSeiichi KatoKazuyuki ShimadaTsutomu TanakaYuka SuzukiAkira SatouKei KohnoAyako SakakibaraTakeshi YamamuraMasanao NakamuraRyoji MiyaharaHidemi GotoShigeo NakamuraYoshiki Hirooka

Published in: Cancer medicine (2018)

EBV+ iDLBCL mainly comprised immunodeficiency-associated patients, which may highlight the specificity of the intestine. PD-L1 expression on tumor cells or microenvironment immune cells was found to have an opposite prognostic impact in iDLBCL.

Keyphrases

epstein barr virus
diffuse large b cell lymphoma
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
stem cells
prognostic factors
peritoneal dialysis
patient reported outcomes